One of the biggest challenges facing the cell and gene therapy industry is how to effectively scale these promising therapies whilst maintaining product quality and minimizing costs of manufacture. Join this webinar with Dr Giulia Detela, VivaBioCell, to hear about the latest advances in tackling the issue of scalability as she discusses:
- The unique scale-out challenges of autologous cell therapy manufacture;
- Equipment criteria and requirements for autologous cell therapy product manufacture;
- First-hand experience of working towards CMC and GMP readiness in your product development;
- A specific case study utilizing the NANT 001 system in an autologous cell therapy process for osteoarthritis treatment.